Published in Hepatology on April 25, 2014
Risk factors for fatty liver in the Multicenter AIDS Cohort Study. Am J Gastroenterol (2014) 1.06
Liver enzymes, metabolomics and genome-wide association studies: from systems biology to the personalized medicine. World J Gastroenterol (2015) 0.96
The impact of PNPLA3 and JAZF1 on hepatocellular carcinoma in non-viral hepatitis patients with type 2 diabetes mellitus. J Gastroenterol (2015) 0.81
Shifts in dietary carbohydrate-lipid exposure regulate expression of the non-alcoholic fatty liver disease-associated gene PNPLA3/adiponutrin in mouse liver and HepG2 human liver cells. Metabolism (2014) 0.79
Genetic predisposition in nonalcoholic fatty liver disease. Clin Mol Hepatol (2017) 0.75
Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease. Hepatology (2011) 5.10
Genetic variation in transmembrane 6 superfamily member 2 and the risk of nonalcoholic fatty liver disease and histological disease severity. Hepatology (2015) 2.48
Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: a systematic review. J Hepatol (2008) 1.71
Meta-analysis on the G-308A tumor necrosis factor alpha gene variant and phenotypes associated with the metabolic syndrome. Obes Res (2005) 1.56
A1166C angiotensin II type 1 receptor gene polymorphism may predict hemodynamic response to losartan in patients with cirrhosis and portal hypertension. Am J Gastroenterol (2005) 1.52
Cardiac thyrotropin-releasing hormone mediates left ventricular hypertrophy in spontaneously hypertensive rats. Hypertension (2010) 1.41
Epigenetic regulation of insulin resistance in nonalcoholic fatty liver disease: impact of liver methylation of the peroxisome proliferator-activated receptor γ coactivator 1α promoter. Hepatology (2010) 1.38
Maternal pregestational BMI is associated with methylation of the PPARGC1A promoter in newborns. Obesity (Silver Spring) (2009) 1.24
Alanine and aspartate aminotransferase and glutamine-cycling pathway: their roles in pathogenesis of metabolic syndrome. World J Gastroenterol (2012) 1.19
Low Mpl receptor expression in a pedigree with familial platelet disorder with predisposition to acute myelogenous leukemia and a novel AML1 mutation. Blood (2005) 1.18
Association of the multidrug-resistance-associated protein gene (ABCC2) variants with intrahepatic cholestasis of pregnancy. J Hepatol (2007) 1.16
Circulating MicroRNA-122 signature in nonalcoholic fatty liver disease and cardiovascular disease: a new endocrine system in metabolic syndrome. Hepatology (2013) 1.13
A decreased mitochondrial DNA content is related to insulin resistance in adolescents. Obesity (Silver Spring) (2008) 1.07
High fat diet-induced liver steatosis promotes an increase in liver mitochondrial biogenesis in response to hypoxia. J Cell Mol Med (2010) 1.05
Loci from a genome-wide analysis of bilirubin levels are associated with gallstone risk and composition. Gastroenterology (2010) 1.02
Liver transcriptional profile of atherosclerosis-related genes in human nonalcoholic fatty liver disease. Atherosclerosis (2011) 1.01
Contribution of the functional 5-HTTLPR variant of the SLC6A4 gene to obesity risk in male adults. Obesity (Silver Spring) (2008) 1.01
Mitochondrial DNA depletion in small- and large-for-gestational-age newborns. Obesity (Silver Spring) (2006) 1.00
Fetal metabolic programming and epigenetic modifications: a systems biology approach. Pediatr Res (2013) 1.00
PNPLA3, the triacylglycerol synthesis/hydrolysis/storage dilemma, and nonalcoholic fatty liver disease. World J Gastroenterol (2012) 0.97
Obstructive sleep apnea is associated with fatty liver and abnormal liver enzymes: a meta-analysis. Obes Surg (2013) 0.97
The genetic epidemiology of nonalcoholic fatty liver disease: toward a personalized medicine. Clin Liver Dis (2012) 0.97
Angiotensin-(1-7) through AT receptors mediates tyrosine hydroxylase degradation via the ubiquitin-proteasome pathway. J Neurochem (2009) 0.95
Short allele of serotonin transporter gene promoter is a risk factor for obesity in adolescents. Obesity (Silver Spring) (2007) 0.94
Methylation of TFAM gene promoter in peripheral white blood cells is associated with insulin resistance in adolescents. Mol Genet Metab (2010) 0.91
Metabolic syndrome: from the genetics to the pathophysiology. Curr Hypertens Rep (2011) 0.88
Association between diencephalic thyroliberin and arterial blood pressure in agouti-yellow and ob/ob mice may be mediated by leptin. Metabolism (2007) 0.87
The G-308A promoter variant of the tumor necrosis factor-alpha gene is associated with hypertension in adolescents harboring the metabolic syndrome. Am J Hypertens (2005) 0.86
Losartan reduces liver expression of plasminogen activator inhibitor-1 (PAI-1) in a high fat-induced rat nonalcoholic fatty liver disease model. Atherosclerosis (2009) 0.86
DNA methylation and hepatic insulin resistance and steatosis. Curr Opin Clin Nutr Metab Care (2012) 0.84
Mitochondrial DNA copy number is modulated by genetic variation in the signal transducer and activator of transcription 3 (STAT3). Metabolism (2011) 0.84
Influence of hepatocyte nuclear factor 4alpha (HNF4alpha) gene variants on the risk of type 2 diabetes: a meta-analysis in 49,577 individuals. Mol Genet Metab (2010) 0.83
Knocking down the diencephalic thyrotropin-releasing hormone precursor gene normalizes obesity-induced hypertension in the rat. Am J Physiol Endocrinol Metab (2007) 0.83
Systems biology elucidates common pathogenic mechanisms between nonalcoholic and alcoholic-fatty liver disease. PLoS One (2013) 0.83
Modest alcohol consumption decreases the risk of non-alcoholic fatty liver disease: a meta-analysis of 43 175 individuals. Gut (2013) 0.82
Role of genetic variation in insulin-like growth factor 1 receptor on insulin resistance and arterial hypertension. J Hypertens (2010) 0.82
Renin-angiotensin-aldosterone system loci and multilocus interactions in young-onset essential hypertension. Clin Exp Hypertens (2003) 0.80
Genetics of the cardiometabolic syndrome: new insights and therapeutic implications. Ther Adv Cardiovasc Dis (2007) 0.79
Cardiovascular disease is associated with high-fat-diet-induced liver damage and up-regulation of the hepatic expression of hypoxia-inducible factor 1α in a rat model. Clin Sci (Lond) (2013) 0.79
Shift work and subclinical atherosclerosis: recommendations for fatty liver disease detection. Atherosclerosis (2009) 0.78
Epigenetics of insulin resistance: an emerging field in translational medicine. Curr Diab Rep (2013) 0.78
Thyrotropin-releasing hormone in cardiovascular pathophysiology. Regul Pept (2005) 0.77
Should nonalcoholic fatty liver disease be included in the definition of metabolic syndrome? A cross-sectional comparison with adult treatment panel III criteria in nonobese nondiabetic subjects: response to Musso et al. Diabetes Care (2008) 0.77
Study of genetic variation in the STAT3 on obesity and insulin resistance in male adults. Obesity (Silver Spring) (2008) 0.77
Thyrotropin-releasing hormone decreases leptin and mediates the leptin-induced pressor effect. Hypertension (2002) 0.77
PNPLA3 I148M variant is associated with metabolic stress-response phenotype in patients with nonalcoholic fatty liver disease. Hepatology (2015) 0.77
The impact of maternal high-fat feeding on liver and abdominal fat accumulation in adult offspring under a long-term high-fat diet. Hepatology (2010) 0.76
Genetic variation in the FAAH gene and metabolic syndrome-related phenotypes. Obesity (Silver Spring) (2009) 0.76
Normal platelets possess the soluble form of IL-6 receptor. Cytokine (2005) 0.76
PDGF-A, PDGF-B, TGFbeta, and bFGF mRNA levels in patients with essential thrombocythemia treated with anagrelide. Am J Hematol (2005) 0.76
Insulin resistance and epigenetic regulation: insights from human studies and prospects for future research. Biomol Concepts (2011) 0.76
Thyrotropin-releasing hormone precursor gene knocking down impedes melanocortin-induced hypertension in rats. Hypertension (2008) 0.75
Letter by Landa et al regarding article, "Protein tyrosine phosphatase 1B, a major regulator of leptin-mediated control of cardiovascular function". Circulation (2010) 0.75
Genetic predisposition in nonalcoholic fatty liver disease. Clin Mol Hepatol (2017) 0.75
Cardiovascular phenotype of nonalcoholic fatty liver disease: hanging the paradigm about the role of distant toxic fat accumulation on vascular disease. Hepatology (2012) 0.75
Targeting the renin-angiotensin system: potential beneficial effects of the angiotensin II receptor blockers in patients with nonalcoholic steatohepatitis. Hepatology (2011) 0.75
Genetic variation in long noncoding RNAs and the risk of nonalcoholic fatty liver disease. Oncotarget (2017) 0.75
Cyclooxygenase inhibition up-regulates liver carnitine palmitoyltransferase 1A expression and improves fatty liver. Hepatology (2011) 0.75
Parathyroid hormone-related protein overexpression decreases blood pressure in spontaneously hypertensive rats. Clin Exp Hypertens (2005) 0.75
[Pharmacogenetics/pharmacogenomics in clinical practice]. Medicina (B Aires) (2004) 0.75